122 related articles for article (PubMed ID: 34864653)
1. Evaluation of molecular apoptosis signaling pathways and its correlation with EBV viral load in SLE patients using systems biology approach.
Ghabeshi S; Najafi A; Zamani B; Soltani M; Arero AG; Izadi S; Piroozmand A
Hum Antibodies; 2022; 30(1):37-46. PubMed ID: 34864653
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus.
Poole BD; Templeton AK; Guthridge JM; Brown EJ; Harley JB; James JA
Autoimmun Rev; 2009 Feb; 8(4):337-42. PubMed ID: 19167523
[TBL] [Abstract][Full Text] [Related]
3. Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan.
Yu SF; Wu HC; Tsai WC; Yen JH; Chiang W; Yuo CY; Lu SN; Chiang LC; Chen CJ
Med Microbiol Immunol; 2005 May; 194(3):115-20. PubMed ID: 15378356
[TBL] [Abstract][Full Text] [Related]
4. Overall Status of Epstein-Barr virus Infection, IFN-a, and TLR-7/9 in Patients with Systemic Lupus Erythematous.
Izadi S; Najafizadeh SR; Nejati A; Teymoori-Rad M; Shahmahmoodi S; Golsaz Shirazi F; Shokri F; Marashi SM
Iran J Immunol; 2021 Sep; 18(3):230-240. PubMed ID: 34596588
[TBL] [Abstract][Full Text] [Related]
5. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood.
Moon UY; Park SJ; Oh ST; Kim WU; Park SH; Lee SH; Cho CS; Kim HY; Lee WK; Lee SK
Arthritis Res Ther; 2004; 6(4):R295-302. PubMed ID: 15225364
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
7. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
8. Lupus and Epstein-Barr.
James JA; Robertson JM
Curr Opin Rheumatol; 2012 Jul; 24(4):383-8. PubMed ID: 22504579
[TBL] [Abstract][Full Text] [Related]
9. Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing Systemic Lupus Erythematosus.
Afrasiabi A; Keane JT; Ong LTC; Alinejad-Rokny H; Fewings NL; Booth DR; Parnell GP; Swaminathan S
J Autoimmun; 2022 Feb; 127():102781. PubMed ID: 34952359
[TBL] [Abstract][Full Text] [Related]
10. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
Kang I; Quan T; Nolasco H; Park SH; Hong MS; Crouch J; Pamer EG; Howe JG; Craft J
J Immunol; 2004 Jan; 172(2):1287-94. PubMed ID: 14707107
[TBL] [Abstract][Full Text] [Related]
11. EBV load is associated with cfDNA fragmentation and renal damage in SLE patients.
Truszewska A; Wirkowska A; Gala K; Truszewski P; Krzemień-Ojak Ł; Mucha K; Pączek L; Foroncewicz B
Lupus; 2021 Jul; 30(8):1214-1225. PubMed ID: 33866897
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
13. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
Chougule D; Nadkar M; Rajadhyaksha A; Pandit-Shende P; Surve P; Dawkar N; Khadilkar P; Patwardhan M; Kaveri S; Ghosh K; Pradhan V
J Med Virol; 2018 Mar; 90(3):559-563. PubMed ID: 28734074
[TBL] [Abstract][Full Text] [Related]
14. High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus.
Tung YC; Ke LY; Tsai SM; Lu PL; Tsai WC
Int J Rheum Dis; 2013 Dec; 16(6):709-14. PubMed ID: 24283670
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and systemic lupus erythematosus.
Draborg AH; Duus K; Houen G
Clin Dev Immunol; 2012; 2012():370516. PubMed ID: 22811739
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study.
Piroozmand A; Haddad Kashani H; Zamani B
Asian Pac J Cancer Prev; 2017 Feb; 18(2):523-527. PubMed ID: 28345840
[TBL] [Abstract][Full Text] [Related]
17. Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
Larsen M; Sauce D; Deback C; Arnaud L; Mathian A; Miyara M; Boutolleau D; Parizot C; Dorgham K; Papagno L; Appay V; Amoura Z; Gorochov G
PLoS Pathog; 2011 Oct; 7(10):e1002328. PubMed ID: 22028659
[TBL] [Abstract][Full Text] [Related]
18. EBV and systemic lupus erythematosus: a new perspective.
Gross AJ; Hochberg D; Rand WM; Thorley-Lawson DA
J Immunol; 2005 Jun; 174(11):6599-607. PubMed ID: 15905498
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
[TBL] [Abstract][Full Text] [Related]
20. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
Incaprera M; Rindi L; Bazzichi A; Garzelli C
Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
